ReadYourDNA

Opioids (class)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Opioids

What it is

Opioids are a class of pain medicines that act on the body's opioid receptors, mainly the mu receptor, in the brain, spinal cord and gut. The class includes morphine, codeine, oxycodone, hydrocodone, fentanyl, tramadol, methadone and others. They are used for moderate to severe pain and, some of them, for cough, diarrhoea or the treatment of opioid dependence. This page collects studies that looked at opioids as a group.

How genes come into it

For the class as a whole, the most studied gene is OPRM1, which makes the mu opioid receptor; its A118G variant (rs1799971) has been linked in some studies to needing more opioid for the same pain relief. COMT, the transporter ABCB1 and dopamine receptor genes have also been studied, mostly for dose needs and dependence, with mixed results. The strongest gene evidence is for individual opioids rather than the class: CYP2D6 for codeine, tramadol and hydrocodone, each with its own page and guideline.

What research found

Every published finding on gene variants and Opioids. Upload your DNA file to see which of these rows apply to you.

Rated evidence (97 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

OPRM1 rs1799971: Level 3. Dosage: Pain, Pain, Postoperative. 8.

COMT rs4680: Level 3. Dosage: Pain, Pain, Postoperative. 6.

ABCB1 rs1045642: Level 3. Dosage: Pain, Pain, Postoperative. 6.

OPRM1 rs1799971: Level 3. Toxicity: adverse events, Nausea, Vomiting. 4.

Response (8 findings)

Studies of how well it worked in people carrying a variant.

rs2952768: Genotype CC is associated with decreased response to opioids in people with Pain, Postoperative as compared to genotypes CT + TT.

COMT rs4680: Genotypes AA + AG are associated with increased response to opioids in children as compared to genotype GG.

CYP2D6 CYP2D6 poor and ultrarapid metabolizers: CYP2D6 poor and ultrarapid metabolizers are associated with decreased response to opioids in people with Pain as compared to CYP2D6 intermediate metabolizer and normal metabolizer.

IL1B rs1143634: Genotypes AA + AG is associated with decreased clinical benefit to opioids in people with Pain and Neoplasms as compared to genotype GG.

Dosing (150 findings)

Studies of how much of the drug people needed or tolerated.

ABCB1 rs1045642: Genotype AA is associated with decreased dose of opioids in people with Pain, Postoperative as compared to genotypes AG + GG.

ABCB1 rs1045642: Genotype AA is associated with decreased dose of opioids in people with Neoplasms and Pain as compared to genotypes AG + GG.

BDNF rs6265: Genotype CC is associated with increased dose of opioids in people with Pain and Neoplasms as compared to genotypes CT + TT.

COMT rs4680: Genotype GG is associated with increased dose of opioids in people with Pain, Postoperative as compared to genotype AA.

Other findings (1 finding)

Studies that do not fall into the groups above.

KCNJ6 rs2070995: Genotype TT is associated with increased dose of opioids in people with Pain as compared to genotypes CC + CT.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Alfenta (Opioids)

Codeine (Opioids)

Demerol (Opioids)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com